While several clinical studies have observed dysregulated miR-21 levels in exosomes or serum of asthmatic patients, showing correlations with disease severity such as IgE, IL-4, and lung function [187], no clinical trials have yet tested miRNA-based therapeutics in asthma. This evidence concerns the gene IGHE and asthma.